Status:
NOT_YET_RECRUITING
Using Machine Learning and Biomarkers for Early Detection of Delayed Cerebral Ischemia
Lead Sponsor:
Sahlgrenska University Hospital
Conditions:
Ischemic Stroke
Hemorrhagic Stroke
Eligibility:
All Genders
18-110 years
Brief Summary
The overall goal of this project is to determine if machine learning and analysis of neurospecific biomarkers can enable early detection of upcoming or ongoing cerebral ischaemia in patients suffering...
Detailed Description
A new and promising approach to detect ongoing cerebral ischemia might be the detection of neurospecific biomarkers in blood. A biomarker for cerebral ischaemia, similar to troponin T and troponin I f...
Eligibility Criteria
Inclusion
- Patients over the age of 18 with aneurysmal subarachnoid hemorrhage admitted to intensive care units at Sahlgrenska University hospital.
Exclusion
- Unable to consent,
- Cardiac arrythmia,
- Previous brain damage
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2033
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT06069973
Start Date
September 1 2024
End Date
December 31 2033
Last Update
February 9 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.